Smarter partners helping you make smarter choices
White Papers

Ozempic and Other GLP‑1 Drugs: All Hype or Actually Helpful?

Should weight loss drugs be on your pharmacy plans? Explore the GLP-1 drug landscape and the latest clinical considerations to guide brokers, benefits advisors, and employers in making decisions on pharmaceutical benefits to treat obesity.

VIEW

Navigating J Codes with Patient Care

J Codes are used to charge medications to the medical benefit. Plans may be paying two-fold, three-fold, or more for the cost of a drug. How can you avoid this pitfall and maintain quality treatment? Download the white paper with an innovative answer to high cost medications, "Navigating J Code Solutions with Patient Care."

VIEW

Understanding Orphan Medications

With new orphan medications on the market with a price tag of more than $1 million a year, it is important to understand this category of drugs. Download our white paper to learn more industry knowledge, "Understanding Orphan Medications."

VIEW

Factors Affecting the Cost of Diabetes Management

With over 30 million diagnosed patients, diabetes management is one of the leading cost drivers of healthcare expenses in the United States. For answers to these rising costs and pharmacy solutions, download our white paper on "Factors Affecting the Cost of Diabetes Management".

VIEW